NCT06098404 Correlates of CRCI and Gut Microbiome Dysbiosis; a Pilot Study
| NCT ID | NCT06098404 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Texas Medical Branch, Galveston |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2024-03-04 |
| Primary Completion | 2026-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2024-03-04 with a primary completion date of 2026-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to characterize the microbiome and assess fatigue and cognition of patients with cancer undergoing standard of care treatment.
Eligibility Criteria
Inclusion Criteria: 1. Current diagnosis of cancer. 2. Ages 18 and over. 3. Has access to a device (smart phone, computer, tablet) with internet access. 4. Participant is willing and able to give informed consent for participation in the study. Exclusion Criteria: 1. Females who are pregnant or lactating. 2. Other medical conditions or medications deemed exclusionary by the study investigators.
Contact & Investigator
Melinda Sheffield-Moore, PhD
PRINCIPAL INVESTIGATOR
University of Texas
Frequently Asked Questions
Who can join the NCT06098404 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06098404 currently recruiting?
Yes, NCT06098404 is actively recruiting participants. Contact the research team at kmrandol@utmb.edu for enrollment information.
Where is the NCT06098404 trial being conducted?
This trial is being conducted at Galveston, United States.
Who is sponsoring the NCT06098404 clinical trial?
NCT06098404 is sponsored by The University of Texas Medical Branch, Galveston. The principal investigator is Melinda Sheffield-Moore, PhD at University of Texas. The trial plans to enroll 250 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.